TOG Review (RCOG Journal)

MRCOG Part 2

Subfertility and Reproductive Medicine

New technologies for the management of ovarian ageing

Key Statistics

  • 1–2 million — Primordial follicles at birth
  • ~1000 — Follicles remaining at menopause
  • 60% / 18.4% — Pregnancy rate / cumulative LBR, ovarian fragmentation in POI

Don't-miss facts

  1. Egg donation is the only POI treatment with established clinical effectiveness – all technologies below are experimental/not regulator-approved

  2. Ovarian fragmentation (no stimulation) in POI: pregnancy rate up to 60%, cumulative LBR 18.4%

  3. G-CSF-stimulated autologous bone marrow: 81.3% improved ovarian function, 29% pregnancy rate, but does not correct aneuploidy

  4. PRP: pooled pregnancy rate 22%; RCT shows no gain in euploid blastocysts/term pregnancy despite more mature oocytes

  5. Maternal spindle transfer: 6/28 (21%) livebirths – latest mitochondrial replacement technique, avoids heteroplasmy

  6. CoQ10 pre-treatment: clinical pregnancy rate 28.8% vs 14.1% but no livebirth/miscarriage benefit (surrogate outcome trap)

  7. Quantity-targeting techniques (IVG, follicular activation, stem cell, PRP, artificial ovary) vs quality-targeting techniques (mitochondrial replacement, gene editing, senotherapies)

Quantity vs quality – therapeutic targets

Quantity: IVG · follicular activation · stem cell · PRP · artificial ovary

Quality: mitochondrial replacement · gene editing (CRISPR-Cas9) · senotherapies

Abbreviation Key

  • POI — premature ovarian insufficiency
  • S1P — sphingosine-1-phosphate
  • AGE — advanced glycation end products
  • IGF-1 — insulin-like growth factor 1
  • ROS — reactive oxygen species
  • NAD/NADH — nicotinamide adenine dinucleotide (oxidised/reduced)
  • iPSC — induced pleuripotent stem cell
  • NMN — nicotinamide mononucleotide
  • CRISPR-Cas9 — clustered regularly interspaced short palindromic
  • NR — nicotinamide riboside repeats – CRISPR associated protein 9 (gene-editing nuclease)
  • CoQ10 — coenzyme Q10
  • PRP — platelet-rich plasma
  • LBR — livebirth rate
  • G-CSF — granulocyte colony-stimulating factor
  • ATP — adenosine triphosphate
  • VEGF — vascular endothelial growth factor
  • MII — metaphase II (oocyte)
  • PDGF-AB — platelet-derived growth factor AB
  • IVF — in vitro fertilisation
  • TGF — transforming growth factor
  • Akt — protein kinase B

Source: Woon EV, Ibeto L, Nikolaou D. New technologies for the management of ovarian ageing. The Obstetrician & Gynaecologist 2025;27:136–141. doi:10.1111/tog.12972

MRCOG AI is an independent educational tool. It is not affiliated with, endorsed by, or connected to the Royal College of Obstetricians and Gynaecologists (RCOG).

Included with a Pass Package

  • Audio overview of this guideline
  • Practice questions drawn from it
  • AI tutor answers grounded in its text
  • Your own annotations
Start free